協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/02/13 | 2,763 | 2,835 | 2,737 | 2,824.5 | +61.5 | +2.2% | 2,583,300 |
2024/02/09 | 2,727.5 | 2,769 | 2,691 | 2,763 | +55.5 | +2% | 2,868,000 |
2024/02/08 | 2,618 | 2,723.5 | 2,568 | 2,707.5 | +439.5 | +19.4% | 6,675,300 |
2024/02/07 | 2,320 | 2,320 | 2,266.5 | 2,268 | -54 | -2.3% | 1,239,000 |
2024/02/06 | 2,314 | 2,326 | 2,285 | 2,322 | +9.5 | +0.4% | 913,600 |
2024/02/05 | 2,315 | 2,335 | 2,312 | 2,312.5 | -1 | ±0% | 705,900 |
2024/02/02 | 2,317.5 | 2,335.5 | 2,311.5 | 2,313.5 | +3.5 | +0.2% | 659,100 |
2024/02/01 | 2,315 | 2,318.5 | 2,288.5 | 2,310 | -23.5 | -1% | 700,700 |
2024/01/31 | 2,286 | 2,342 | 2,284 | 2,333.5 | +29 | +1.3% | 1,343,400 |
2024/01/30 | 2,327 | 2,344 | 2,304.5 | 2,304.5 | -22 | -0.9% | 853,400 |
2024/01/29 | 2,345.5 | 2,346 | 2,319.5 | 2,326.5 | -12 | -0.5% | 1,022,100 |
2024/01/26 | 2,344.5 | 2,352 | 2,337 | 2,338.5 | -15 | -0.6% | 717,900 |
2024/01/25 | 2,365.5 | 2,388.5 | 2,340 | 2,353.5 | -23 | -1% | 786,700 |
2024/01/24 | 2,400 | 2,417 | 2,374 | 2,376.5 | -9 | -0.4% | 841,400 |
2024/01/23 | 2,367 | 2,397.5 | 2,367 | 2,385.5 | +22 | +0.9% | 833,300 |
2024/01/22 | 2,340.5 | 2,369 | 2,336 | 2,363.5 | +20 | +0.9% | 755,000 |
2024/01/19 | 2,364 | 2,369.5 | 2,331.5 | 2,343.5 | -33.5 | -1.4% | 1,144,400 |
2024/01/18 | 2,376.5 | 2,390.5 | 2,361 | 2,377 | -14 | -0.6% | 774,500 |
2024/01/17 | 2,422 | 2,427 | 2,380.5 | 2,391 | -34.5 | -1.4% | 1,166,700 |
2024/01/16 | 2,443 | 2,455.5 | 2,421 | 2,425.5 | -37 | -1.5% | 757,400 |
2024/01/15 | 2,478 | 2,482 | 2,442 | 2,462.5 | -23.5 | -0.9% | 1,001,900 |
2024/01/12 | 2,576 | 2,576 | 2,473 | 2,486 | -42.5 | -1.7% | 1,548,900 |
2024/01/11 | 2,541 | 2,557 | 2,517 | 2,528.5 | -4.5 | -0.2% | 1,023,000 |
2024/01/10 | 2,494 | 2,537 | 2,487.5 | 2,533 | +61.5 | +2.5% | 1,246,700 |
2024/01/09 | 2,426 | 2,484 | 2,425 | 2,471.5 | +57 | +2.4% | 1,107,300 |
2024/01/05 | 2,451 | 2,451 | 2,414.5 | 2,414.5 | -20 | -0.8% | 808,200 |
2024/01/04 | 2,390 | 2,437 | 2,366.5 | 2,434.5 | +64.5 | +2.7% | 925,700 |
2023/12/29 | 2,366.5 | 2,373 | 2,356.5 | 2,370 | +5 | +0.2% | 650,700 |
2023/12/28 | 2,333 | 2,365 | 2,330.5 | 2,365 | -18 | -0.8% | 618,000 |
2023/12/27 | 2,370.5 | 2,392 | 2,360 | 2,383 | +28 | +1.2% | 1,038,400 |
2023/12/26 | 2,355.5 | 2,368.5 | 2,348.5 | 2,355 | +4.5 | +0.2% | 559,100 |
2023/12/25 | 2,368 | 2,380 | 2,350.5 | 2,350.5 | +9.5 | +0.4% | 384,300 |
2023/12/22 | 2,333.5 | 2,348.5 | 2,325 | 2,341 | +20 | +0.9% | 699,000 |
2023/12/21 | 2,370.5 | 2,379 | 2,320 | 2,321 | -63 | -2.6% | 946,100 |
2023/12/20 | 2,381.5 | 2,419 | 2,378 | 2,384 | +5 | +0.2% | 671,500 |
2023/12/19 | 2,391 | 2,395.5 | 2,353 | 2,379 | -9.5 | -0.4% | 583,100 |
2023/12/18 | 2,385.5 | 2,407 | 2,379.5 | 2,388.5 | -23.5 | -1% | 582,500 |
2023/12/15 | 2,435 | 2,441.5 | 2,397.5 | 2,412 | -32.5 | -1.3% | 1,210,000 |
2023/12/14 | 2,469.5 | 2,471.5 | 2,429 | 2,444.5 | -13 | -0.5% | 689,600 |
2023/12/13 | 2,469.5 | 2,471.5 | 2,450.5 | 2,457.5 | -1 | ±0% | 645,100 |
2023/12/12 | 2,459 | 2,479.5 | 2,442.5 | 2,458.5 | +5.5 | +0.2% | 1,004,500 |
2023/12/11 | 2,414.5 | 2,457 | 2,407.5 | 2,453 | +69 | +2.9% | 1,022,500 |
2023/12/08 | 2,389 | 2,389 | 2,363 | 2,384 | -27 | -1.1% | 1,303,200 |
2023/12/07 | 2,416 | 2,432.5 | 2,395.5 | 2,411 | -27.5 | -1.1% | 822,000 |
2023/12/06 | 2,431.5 | 2,444 | 2,421 | 2,438.5 | +12.5 | +0.5% | 897,400 |
2023/12/05 | 2,408.5 | 2,434.5 | 2,405.5 | 2,426 | +18 | +0.7% | 1,015,300 |
2023/12/04 | 2,400 | 2,408 | 2,377 | 2,408 | -13 | -0.5% | 706,200 |
2023/12/01 | 2,440 | 2,448.5 | 2,411 | 2,421 | -16 | -0.7% | 859,000 |
2023/11/30 | 2,429.5 | 2,438.5 | 2,407 | 2,437 | +5.5 | +0.2% | 1,710,700 |
2023/11/29 | 2,420 | 2,431.5 | 2,410 | 2,431.5 | -9 | -0.4% | 752,000 |
201~
250
件表示中 / 3594件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 244,500円 | +11.3% | -5.4% | 2.37% | 18.82倍 | 1.48倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 215,500円 | +5.7% | +3.9% | 2.66% | 10.72倍 | 1.42倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 451,400円 | +1.7% | -2.9% | 3.54% | 29.62倍 | 1.55倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 174,500円 | -3.5% | -50.2% | 4.58% | 14.13倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 288,000円 | +18.2% | +4.2% | 1.15% | 20.41倍 | 2.60倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム